首页> 外文期刊>Urolithiasis. >In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers
【24h】

In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers

机译:石灰粉方案(LPR)的体外抗石蜡活性和LPR对健康志愿者肾结石形成尿路危险因素的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Hypocitraturia, hypokaliuria, and increased oxidative stress are common lithogenic risk factors found in nephrolithiasis patients, especially in Thailand. We previously developed lime powder regimen (LPR), and demonstrated that LPR delivered citraturic, alkalinizing, and antioxidative effects in kidney stone patients. In this study, in vitro anti-lithogenic activity, in vivo acute toxicity, and crossover-designed phase 1 trial (in 13 healthy volunteers) of LPR were investigated. LPR inhibited the growth of calcium oxalate monohydrate (COM) crystals in dose-dependent manner, and inhibited the intracellular production of reactive oxygen species (ROS) in COM-treated HK-2 cells. LPR did not significantly alter viability of HK-2 cells. No acute toxicity was detected in mice orally fed with LPR (10 g/kg). No adverse effect and complaint of LPR ingestion (5 g/dose) were observed in the tested volunteers. Plasma citrate was elevated at 30 min after LPR load, which was higher than the water load control. Plasma potassium was significantly elevated at 30 min after LPR load and remained high for 2 h, and at 2 h, it was significantly higher than the water load. Urinary citrate was significantly increased at 1 h after LPR load and remained high for 2 h, and at 2 h, it was significantly higher than the water load. Urinary potassium was significantly increased at 1 h after LPR load and remained high for 3 h, and its levels at 1, 2, and 3 h were significantly higher than the water load. Urinary total antioxidant status was significantly increased at 2 h after LPR load. In conclusion, LPR had an inhibitory effect on COM growth and exerted as antioxidant to attenuate ROS production in the COM-treated renal tubular cells. LPR provided citraturic, kaliuric, and antioxidative responses in healthy individuals without any adverse events. This suggests that LPR is well tolerated and safe for daily consumption.
机译:低尿酸,低尿症和氧化应激增加是肾结石病患者(尤其是泰国)发现的常见致石症危险因素。我们之前开发了石灰粉疗法(LPR),并证明LPR在肾结石患者中具有柠檬酸,碱化和抗氧化作用。在这项研究中,研究了LPR的体外抗结石活性,体内急性毒性和交叉设计的1期试验(在13名健康志愿者中)。 LPR以剂量依赖性方式抑制草酸钙一水合物(COM)晶体的生长,并抑制COM处理过的HK-2细胞内活性氧(ROS)的细胞内产生。 LPR不会显着改变HK-2细胞的生存能力。在口服LPR(10 g / kg)的小鼠中未检测到急性毒性。在测试的志愿者中未观察到不良反应和LPR摄入(5克/剂量)的抱怨。 LPR负荷后30分钟血浆柠檬酸盐升高,高于水负荷对照。在LPR负荷后30分钟,血浆钾显着升高,并在2 h内保持较高水平,而在2 h时,血浆钾显着高于水负荷。 LPR负荷后1 h尿中的柠檬酸盐显着增加,并维持2 h较高,而2 h时尿中柠檬酸显着高于水负荷。 LPR负荷后1 h尿钾显着增加,并保持3 h较高,其在1,2和3 h的水平显着高于水负荷。 LPR负荷后2 h尿中总抗氧化剂状态显着增加。总之,LPR对COM的生长具有抑制作用,并作为抗氧化剂来减弱COM处理的肾小管细胞中ROS的产生。 LPR在健康个体中提供柠檬酸,卡利尿酸和抗氧化反应,没有任何不良事件。这表明LPR具有良好的耐受性,并且每天食用安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号